Loading clinical trials...
Loading clinical trials...
Assessing Vericiguat for the Management of Heart Failure With Reduced Ejection Fraction Using HealthVerity Data
Conditions
Locations
1
Germany
Bayer
Berlin, Germany
Start Date
July 11, 2023
Primary Completion Date
October 8, 2024
Completion Date
October 8, 2024
Last Updated
November 1, 2024
NCT06148935
NCT06632483
NCT05093933
NCT06697353
NCT06363110
NCT02768298
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions